COVID-19 Vaccine Acceptance Among Parents of Children With Multisystem Inflammatory Syndrome in Children

the Swissped RECOVERY Trial Group; Geraldine Blanchard-Rohner; Carlos Sanchez; Maya C. Andre; Sabrina Bressieux-Degueldre; Serge Grazioli; Marie Helene Perez; Daniela Wütz; Nina Schöbi; Tatjana Welzel; Andrew Atkinson; Luregn J. Schlapbach; Julia A. Bielicki; Johannes Trück; Henrik Koehler; Spyridoula Gysi; Indra Janz; Andreas Bieri; Bir Donner; Jürg Hammer; Ulrich Heininger; Clemens von Kalckreuth; Malte Kohns; Nicole Mettauer; Alexandra Meyer; Diana Reppucci; Chloé Schlaeppi; Daniel Trachsel; Nina Vaezipour; Andreas Woerner; Andreas Zutter; Federica Vanoni; Lisa Kottanattu; Calogero Mazzara; Alessia Severi Conti; Christoph Aebi; Philipp Agyeman; Andrea Duppenthaler; Martin Glöckler; Sabine Pallivathukal; Thomas Riedel; Petra Zimmermann; Hong Phuc Cudré-Cung; Mladen Pavlovic; Alice Bordessoule; Anne Laure Martin; Angelo Polito; Noemie Wagner; Marie Rohr; Arnaud L’Huillier; Vivianne Amiet; Thomas Ferry; David Longchamp; Julia Natterer; Rebecca Oppenheim; Michael Hofer; Michael Buettcher; Katharina Wechselberger; Alex Donas; Sara Germann; Michaela Lütolf Erni; Daniela Kaiser; Katharina Schwendener Scholl; Hans Peter Kuen; Katja Hrup; Janine Stritt; Douggl G.N. Bailey; Tanja Wachinger; Ingrid Beck; André Birkenmaier; Bjarte Rogdo; Philip Lorenz; Ivo Iglowstein; Konstanze Zöhrer; Martin Flade; Seraina Prader; Jana Pachlopnik Schmid; Michelle Seiler; Patrick Meyer Sauteur; Barbara Brotschi; Kathrin Weber; Elizabeth Whittaker; Saul N. Faust

doi:10.1097/INF.0000000000004206

COVID-19 Vaccine Acceptance Among Parents of Children With Multisystem Inflammatory Syndrome in Children

the Swissped RECOVERY Trial Group, Geraldine Blanchard-Rohner, Carlos Sanchez, Maya C. Andre, Sabrina Bressieux-Degueldre, Serge Grazioli, Marie Helene Perez, Daniela Wütz, Nina Schöbi, Tatjana Welzel, Andrew Atkinson, Luregn J. Schlapbach, Julia A. Bielicki, Johannes Trück, Henrik Koehler, Spyridoula Gysi, Indra Janz, Andreas Bieri, Bir Donner, Jürg HammerUlrich Heininger, Clemens von Kalckreuth, Malte Kohns, Nicole Mettauer, Alexandra Meyer, Diana Reppucci, Chloé Schlaeppi, Daniel Trachsel, Nina Vaezipour, Andreas Woerner, Andreas Zutter, Federica Vanoni, Lisa Kottanattu, Calogero Mazzara, Alessia Severi Conti, Christoph Aebi, Philipp Agyeman, Andrea Duppenthaler, Martin Glöckler, Sabine Pallivathukal, Thomas Riedel, Petra Zimmermann, Hong Phuc Cudré-Cung, Mladen Pavlovic, Alice Bordessoule, Anne Laure Martin, Angelo Polito, Noemie Wagner, Marie Rohr, Arnaud L’Huillier, Vivianne Amiet, Thomas Ferry, David Longchamp, Julia Natterer, Rebecca Oppenheim, Michael Hofer, Michael Buettcher, Katharina Wechselberger, Alex Donas, Sara Germann, Michaela Lütolf Erni, Daniela Kaiser, Katharina Schwendener Scholl, Hans Peter Kuen, Katja Hrup, Janine Stritt, Douggl G.N. Bailey, Tanja Wachinger, Ingrid Beck, André Birkenmaier, Bjarte Rogdo, Philip Lorenz, Ivo Iglowstein, Konstanze Zöhrer, Martin Flade, Seraina Prader, Jana Pachlopnik Schmid, Michelle Seiler, Patrick Meyer Sauteur, Barbara Brotschi, Kathrin Weber, Elizabeth Whittaker, Saul N. Faust

Division of Infectious Diseases

Research output: Contribution to journal › Article › peer-review

Abstract

Data on COVID-19 vaccine acceptability among parents of children with multisystem inflammatory syndrome (MIS-C) are limited. In this cohort of children with MIS-C, enrolled in the Swissped RECOVERY trial (NCT 04826588), comparing intravenous immunoglobulins or methylprednisolone, who, in accordance with Swiss guidelines, were recommended for SARS-CoV-2 vaccination, 65% (73/112) of parents reported being vaccinated against SARS-CoV-2 before the MIS-C, while 70% were vaccinated after the MIS-C episode of their child. None of the children were vaccinated before the occurrence of the MIS-C, and only 9% (5/56) received the COVID-19 vaccine after the MIS-C. The predominant barriers to COVID-19 vaccination were concerns over potential side effects and insufficient support from their doctors. This emphasizes the crucial role of health care providers in promoting COVID-19 vaccination among children.

Original language	English
Pages (from-to)	361-364
Number of pages	4
Journal	Pediatric Infectious Disease Journal
Volume	43
Issue number	4
DOIs	https://doi.org/10.1097/INF.0000000000004206
State	Published - Apr 1 2024

Keywords

COVID-19 vaccine
MIS-C
PIMS
SARS-CoV-2
vaccine acceptance

Access to Document

10.1097/INF.0000000000004206

Cite this

the Swissped RECOVERY Trial Group, Blanchard-Rohner, G., Sanchez, C., Andre, M. C., Bressieux-Degueldre, S., Grazioli, S., Perez, M. H., Wütz, D., Schöbi, N., Welzel, T., Atkinson, A., Schlapbach, L. J., Bielicki, J. A., Trück, J., Koehler, H., Gysi, S., Janz, I., Bieri, A., Donner, B., ... Faust, S. N. (2024). COVID-19 Vaccine Acceptance Among Parents of Children With Multisystem Inflammatory Syndrome in Children. Pediatric Infectious Disease Journal, 43(4), 361-364. https://doi.org/10.1097/INF.0000000000004206

@article{abb2260868cd41ee901c91466a6cec8c,

title = "COVID-19 Vaccine Acceptance Among Parents of Children With Multisystem Inflammatory Syndrome in Children",

abstract = "Data on COVID-19 vaccine acceptability among parents of children with multisystem inflammatory syndrome (MIS-C) are limited. In this cohort of children with MIS-C, enrolled in the Swissped RECOVERY trial (NCT 04826588), comparing intravenous immunoglobulins or methylprednisolone, who, in accordance with Swiss guidelines, were recommended for SARS-CoV-2 vaccination, 65% (73/112) of parents reported being vaccinated against SARS-CoV-2 before the MIS-C, while 70% were vaccinated after the MIS-C episode of their child. None of the children were vaccinated before the occurrence of the MIS-C, and only 9% (5/56) received the COVID-19 vaccine after the MIS-C. The predominant barriers to COVID-19 vaccination were concerns over potential side effects and insufficient support from their doctors. This emphasizes the crucial role of health care providers in promoting COVID-19 vaccination among children.",

keywords = "COVID-19 vaccine, MIS-C, PIMS, SARS-CoV-2, vaccine acceptance",

author = "{the Swissped RECOVERY Trial Group} and Geraldine Blanchard-Rohner and Carlos Sanchez and Andre, {Maya C.} and Sabrina Bressieux-Degueldre and Serge Grazioli and Perez, {Marie Helene} and Daniela W{\"u}tz and Nina Sch{\"o}bi and Tatjana Welzel and Andrew Atkinson and Schlapbach, {Luregn J.} and Bielicki, {Julia A.} and Johannes Tr{\"u}ck and Henrik Koehler and Spyridoula Gysi and Indra Janz and Andreas Bieri and Bir Donner and J{\"u}rg Hammer and Ulrich Heininger and {von Kalckreuth}, Clemens and Malte Kohns and Nicole Mettauer and Alexandra Meyer and Diana Reppucci and Chlo{\'e} Schlaeppi and Daniel Trachsel and Nina Vaezipour and Andreas Woerner and Andreas Zutter and Federica Vanoni and Lisa Kottanattu and Calogero Mazzara and Conti, {Alessia Severi} and Christoph Aebi and Philipp Agyeman and Andrea Duppenthaler and Martin Gl{\"o}ckler and Sabine Pallivathukal and Thomas Riedel and Petra Zimmermann and Cudr{\'e}-Cung, {Hong Phuc} and Mladen Pavlovic and Alice Bordessoule and Martin, {Anne Laure} and Angelo Polito and Noemie Wagner and Marie Rohr and Arnaud L{\textquoteright}Huillier and Vivianne Amiet and Thomas Ferry and David Longchamp and Julia Natterer and Rebecca Oppenheim and Michael Hofer and Michael Buettcher and Katharina Wechselberger and Alex Donas and Sara Germann and Erni, {Michaela L{\"u}tolf} and Daniela Kaiser and Scholl, {Katharina Schwendener} and Kuen, {Hans Peter} and Katja Hrup and Janine Stritt and Bailey, {Douggl G.N.} and Tanja Wachinger and Ingrid Beck and Andr{\'e} Birkenmaier and Bjarte Rogdo and Philip Lorenz and Ivo Iglowstein and Konstanze Z{\"o}hrer and Martin Flade and Seraina Prader and Schmid, {Jana Pachlopnik} and Michelle Seiler and Sauteur, {Patrick Meyer} and Barbara Brotschi and Kathrin Weber and Elizabeth Whittaker and Faust, {Saul N.}",

note = "Publisher Copyright: {\textcopyright} 2024 The Author(s).",

year = "2024",

month = apr,

day = "1",

doi = "10.1097/INF.0000000000004206",

language = "English",

volume = "43",

pages = "361--364",

journal = "Pediatric Infectious Disease Journal",

issn = "0891-3668",

number = "4",

}

the Swissped RECOVERY Trial Group, Blanchard-Rohner, G, Sanchez, C, Andre, MC, Bressieux-Degueldre, S, Grazioli, S, Perez, MH, Wütz, D, Schöbi, N, Welzel, T, Atkinson, A, Schlapbach, LJ, Bielicki, JA, Trück, J, Koehler, H, Gysi, S, Janz, I, Bieri, A, Donner, B, Hammer, J, Heininger, U, von Kalckreuth, C, Kohns, M, Mettauer, N, Meyer, A, Reppucci, D, Schlaeppi, C, Trachsel, D, Vaezipour, N, Woerner, A, Zutter, A, Vanoni, F, Kottanattu, L, Mazzara, C, Conti, AS, Aebi, C, Agyeman, P, Duppenthaler, A, Glöckler, M, Pallivathukal, S, Riedel, T, Zimmermann, P, Cudré-Cung, HP, Pavlovic, M, Bordessoule, A, Martin, AL, Polito, A, Wagner, N, Rohr, M, L’Huillier, A, Amiet, V, Ferry, T, Longchamp, D, Natterer, J, Oppenheim, R, Hofer, M, Buettcher, M, Wechselberger, K, Donas, A, Germann, S, Erni, ML, Kaiser, D, Scholl, KS, Kuen, HP, Hrup, K, Stritt, J, Bailey, DGN, Wachinger, T, Beck, I, Birkenmaier, A, Rogdo, B, Lorenz, P, Iglowstein, I, Zöhrer, K, Flade, M, Prader, S, Schmid, JP, Seiler, M, Sauteur, PM, Brotschi, B, Weber, K, Whittaker, E & Faust, SN 2024, 'COVID-19 Vaccine Acceptance Among Parents of Children With Multisystem Inflammatory Syndrome in Children', Pediatric Infectious Disease Journal, vol. 43, no. 4, pp. 361-364. https://doi.org/10.1097/INF.0000000000004206

TY - JOUR

T1 - COVID-19 Vaccine Acceptance Among Parents of Children With Multisystem Inflammatory Syndrome in Children

AU - the Swissped RECOVERY Trial Group

AU - Blanchard-Rohner, Geraldine

AU - Sanchez, Carlos

AU - Andre, Maya C.

AU - Bressieux-Degueldre, Sabrina

AU - Grazioli, Serge

AU - Perez, Marie Helene

AU - Wütz, Daniela

AU - Schöbi, Nina

AU - Welzel, Tatjana

AU - Atkinson, Andrew

AU - Schlapbach, Luregn J.

AU - Bielicki, Julia A.

AU - Trück, Johannes

AU - Koehler, Henrik

AU - Gysi, Spyridoula

AU - Janz, Indra

AU - Bieri, Andreas

AU - Donner, Bir

AU - Hammer, Jürg

AU - Heininger, Ulrich

AU - von Kalckreuth, Clemens

AU - Kohns, Malte

AU - Mettauer, Nicole

AU - Meyer, Alexandra

AU - Reppucci, Diana

AU - Schlaeppi, Chloé

AU - Trachsel, Daniel

AU - Vaezipour, Nina

AU - Woerner, Andreas

AU - Zutter, Andreas

AU - Vanoni, Federica

AU - Kottanattu, Lisa

AU - Mazzara, Calogero

AU - Conti, Alessia Severi

AU - Aebi, Christoph

AU - Agyeman, Philipp

AU - Duppenthaler, Andrea

AU - Glöckler, Martin

AU - Pallivathukal, Sabine

AU - Riedel, Thomas

AU - Zimmermann, Petra

AU - Cudré-Cung, Hong Phuc

AU - Pavlovic, Mladen

AU - Bordessoule, Alice

AU - Martin, Anne Laure

AU - Polito, Angelo

AU - Wagner, Noemie

AU - Rohr, Marie

AU - L’Huillier, Arnaud

AU - Amiet, Vivianne

AU - Ferry, Thomas

AU - Longchamp, David

AU - Natterer, Julia

AU - Oppenheim, Rebecca

AU - Hofer, Michael

AU - Buettcher, Michael

AU - Wechselberger, Katharina

AU - Donas, Alex

AU - Germann, Sara

AU - Erni, Michaela Lütolf

AU - Kaiser, Daniela

AU - Scholl, Katharina Schwendener

AU - Kuen, Hans Peter

AU - Hrup, Katja

AU - Stritt, Janine

AU - Bailey, Douggl G.N.

AU - Wachinger, Tanja

AU - Beck, Ingrid

AU - Birkenmaier, André

AU - Rogdo, Bjarte

AU - Lorenz, Philip

AU - Iglowstein, Ivo

AU - Zöhrer, Konstanze

AU - Flade, Martin

AU - Prader, Seraina

AU - Schmid, Jana Pachlopnik

AU - Seiler, Michelle

AU - Sauteur, Patrick Meyer

AU - Brotschi, Barbara

AU - Weber, Kathrin

AU - Whittaker, Elizabeth

AU - Faust, Saul N.

PY - 2024/4/1

Y1 - 2024/4/1

N2 - Data on COVID-19 vaccine acceptability among parents of children with multisystem inflammatory syndrome (MIS-C) are limited. In this cohort of children with MIS-C, enrolled in the Swissped RECOVERY trial (NCT 04826588), comparing intravenous immunoglobulins or methylprednisolone, who, in accordance with Swiss guidelines, were recommended for SARS-CoV-2 vaccination, 65% (73/112) of parents reported being vaccinated against SARS-CoV-2 before the MIS-C, while 70% were vaccinated after the MIS-C episode of their child. None of the children were vaccinated before the occurrence of the MIS-C, and only 9% (5/56) received the COVID-19 vaccine after the MIS-C. The predominant barriers to COVID-19 vaccination were concerns over potential side effects and insufficient support from their doctors. This emphasizes the crucial role of health care providers in promoting COVID-19 vaccination among children.

AB - Data on COVID-19 vaccine acceptability among parents of children with multisystem inflammatory syndrome (MIS-C) are limited. In this cohort of children with MIS-C, enrolled in the Swissped RECOVERY trial (NCT 04826588), comparing intravenous immunoglobulins or methylprednisolone, who, in accordance with Swiss guidelines, were recommended for SARS-CoV-2 vaccination, 65% (73/112) of parents reported being vaccinated against SARS-CoV-2 before the MIS-C, while 70% were vaccinated after the MIS-C episode of their child. None of the children were vaccinated before the occurrence of the MIS-C, and only 9% (5/56) received the COVID-19 vaccine after the MIS-C. The predominant barriers to COVID-19 vaccination were concerns over potential side effects and insufficient support from their doctors. This emphasizes the crucial role of health care providers in promoting COVID-19 vaccination among children.

KW - COVID-19 vaccine

KW - MIS-C

KW - PIMS

KW - SARS-CoV-2

KW - vaccine acceptance

UR - http://www.scopus.com/inward/record.url?scp=85187205552&partnerID=8YFLogxK

U2 - 10.1097/INF.0000000000004206

DO - 10.1097/INF.0000000000004206

M3 - Article

C2 - 38241661

AN - SCOPUS:85187205552

SN - 0891-3668

VL - 43

SP - 361

EP - 364

JO - Pediatric Infectious Disease Journal

JF - Pediatric Infectious Disease Journal

IS - 4

ER -

COVID-19 Vaccine Acceptance Among Parents of Children With Multisystem Inflammatory Syndrome in Children

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this